Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00289276 · ClinicalTrials.gov registry record · NA
FAST (Fluid Accumulation Status Trial)
A NA study, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- Completed
- Registry status
- NA
- Development phase
- 156
- Enrollment target
NCT00289276 is a NA study that has completed, run by Medtronic Cardiac Rhythm and Heart Failure. The registered enrollment target is 156 participants.
The verdict
NCT00289276, a NA study, has completed, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- COMPLETED
- Registry status
- NA
- Development phase
- 156 participants
- Enrollment target
Study Summary
Heart failure is a progressive disease that decreases the pumping action of the heart. This may cause a backup of fluid in the heart and may result in heart beat changes. Using very low electrical pulses that travel across the inside of the chest cavity, thoracic fluid status monitoring (OptiVol™) can measure the level of resistance to the electrical pulses, which indicates the level of fluid in the chest. The purpose of this study is to collect information related to fluid build up in the chest of subjects with heart failure.
Interventions
- DEVICE Fluid Status Monitoring (OptiVol™)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 156 participants |
| Start Date | 2003-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00289276
The ClinicalTrials.gov registry entry for NCT00289276 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 156 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Cardiac Rhythm and Heart Failure, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Fluid Status Monitoring (OptiVol™) is the first listed.
NCT00289276 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00289276 about?
NCT00289276 is a clinical study titled "FAST (Fluid Accumulation Status Trial)". Heart failure is a progressive disease that decreases the pumping action of the heart. This may cause a backup of fluid in the heart and may result in heart beat changes. Using very low electrical pulses that travel across the inside of the chest cavity, thoracic fluid status monitoring (OptiVol™) c...
What is the current status of trial NCT00289276?
This trial is currently completed. It is a NA study. The enrollment target is 156 participants. The study started on 2003-11.
What interventions are being tested in trial NCT00289276?
The interventions under investigation include: Fluid Status Monitoring (OptiVol™) (DEVICE).
Who is sponsoring clinical trial NCT00289276?
This trial is sponsored by Medtronic Cardiac Rhythm and Heart Failure, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.